Previously unknown species of Aspergillus

Area of Science:

• Medical Mycology
• Clinical Microbiology
• Molecular Diagnostics

Background:

• Classical Aspergillus identification methods are limited, hindering the recognition of 'cryptic' species.
• Cryptic Aspergillus species are prevalent in clinical samples and often exhibit antifungal drug resistance.
• Accurate identification is vital for understanding the clinical significance and epidemiology of these fungi.

Purpose of the Study:

• To evaluate Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) for routine identification of cryptic Aspergillus species.
• To provide insights into the interpretation of positive Aspergillus cultures from clinical samples.
• To enhance the understanding of Aspergillus epidemiology and patient care through accurate fungal identification.

Main Methods:

• Multi-locus DNA sequence analysis for initial species discovery.
• Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) for routine clinical identification.
• Analysis of clinical samples and Aspergillus cultures.

Main Results:

• MALDI-TOF MS provides identification accuracy comparable to DNA sequencing for filamentous fungi.
• The study addresses key interpretation issues for positive Aspergillus cultures.
• Routine MALDI-TOF MS facilitates the identification of cryptic Aspergillus species in clinical laboratories.

Conclusions:

• MALDI-TOF MS is a valuable tool for routine identification of cryptic Aspergillus species in clinical mycology.
• Accurate identification improves the understanding of fungal epidemiology and clinical importance.
• Enhanced identification capabilities will lead to improved patient management and care for fungal infections.